RBC Capital Maintains Select Medical Holdings(SEM.US) With Buy Rating, Cuts Target Price to $19
Select Medical Price Target Cut to $19.00/Share From $23.00 by RBC Capital
Select Medical Is Maintained at Outperform by RBC Capital
Express News | RBC Capital Maintains Outperform on Select Medical Hldgs, Lowers Price Target to $19
Select Medical Hldgs Analyst Ratings
Benchmark Co. Maintains Select Medical Holdings(SEM.US) With Buy Rating, Cuts Target Price to $21
Mizuho Securities Maintains Select Medical Holdings(SEM.US) With Buy Rating, Cuts Target Price to $21
UBS Maintains Select Medical Holdings(SEM.US) With Hold Rating, Cuts Target Price to $15
UBS Adjusts Select Medical Price Target to $15 From $19, Maintains Neutral Rating
Express News | Select Medical Holdings Corp : Benchmark Cuts Target Price to $21 From $23
Earnings Call Summary | Select Medical Holdings(SEM.US) Q1 2025 Earnings Conference
Select Medical Targets $5.3B-$5.5B Revenue Range for 2025 as Inpatient Rehab Expands
Select Medical Holdings Down Over 20%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
12 Health Care Stocks Moving In Friday's Intraday Session
Select Medical Q1 Earnings, Revenue Rise; 2025 Revenue Guidance Trimmed
Select Medical Holdings To Go Ex-Dividend On May 15th, 2025 With 0.0625 USD Dividend Per Share
Express News | Select Medical Hldgs Affirms FY2025 GAAP EPS Guidance of $1.09-$1.19 Vs $1.42 Est; Lowers FY2025 Sales Guidance From $5.40B-$5.60B to $5.30B-$5.50B Vs $5.47B Est
Select Medical Declares $0.0625 Dividend
Select Medical (NYSE:SEM) Misses Q1 Sales Targets, Stock Drops 10.3%
Express News | Select Medical Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Adjusted EPS Results